Nippon Chemiphar Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nippon Chemiphar Co., Ltd. with three other
companies in this sector in Japan:
Eiken Chemical Co., Ltd.
sales of 34.99 billion Japanese Yen [US$311.77 million]
of which 55%
was Immunoserology Test Agent),
Fuso Pharmaceutical Industries Ltd
(45.90 billion Japanese Yen [US$408.97 million]
of which 100%
was Pharmaceutical Business), and
(30.18 billion Japanese Yen [US$268.86 million]
of which 80%
was Pharmaceutical Products).
During the year ended March of 2018, sales at
Nippon Chemiphar Co., Ltd. were ¥35.33 billion (US$314.80 million).
decrease of 1.0%
versus 2017, when the company's sales were ¥35.69 billion.
Contributing to the drop in overall sales was the 7.6% decline
in Other, from ¥1.14 billion to ¥1.05 billion.
There were also decreases in sales in
Pharmaceutical Business (down 0.8% to ¥34.28 billion)